Rolf Myrvold
Papers
1
Total Citations
170
H-Index
1
About
Rolf Myrvold is a leading researcher in antimicrobial resistance and carbohydrate-based therapeutics, with a particular focus on alginate oligosaccharides as adjuvants to combat drug-resistant infections. His most influential work, “Overcoming Drug Resistance with Alginate Oligosaccharides Able To Potentiate the Action of Selected Antibiotics” (2012, 170 citations), demonstrates how low-molecular-weight oligosaccharides can restore the efficacy of conventional antibiotics against resistant pathogens—a breakthrough with profound implications for global health. By targeting biofilm formation and bacterial resistance mechanisms, Myrvold’s research offers a novel, non-toxic strategy to extend the lifespan of existing antibiotics, addressing a critical gap in the fight against superbugs. His contributions have been recognized internationally, and his work continues to inspire new approaches in nanomedicine and antimicrobial stewardship. With a career dedicated to translating fundamental carbohydrate chemistry into practical solutions for drug resistance, Myrvold remains a pivotal figure in the development of next-generation infection therapies.
Research Focus
Key Achievements
Top Papers
- 1